The potential utilization of platelet-derived extracellular vesicles in clinical treatment
- PMID: 39287127
- DOI: 10.1080/09537104.2024.2397592
The potential utilization of platelet-derived extracellular vesicles in clinical treatment
Abstract
Platelet-derived extracellular vesicles (PEVs) are released by platelets in the blood circulation, which carry a rich bio-molecular cargo influential in intercellular communications. PEVs can enter the lymph, bone marrow, and synovial fluid as nano-sized particles, while platelets cannot cross tissue barriers. Considering the advantages of PEVs such as low immunogenicity, high regulation of signal transduction, and easy obtainment, PEVs may be promising therapeutic tools for medical applications. The exceptional functional roles played by PEVs explain the recent interest in exploring new cell-free therapies that could address needs in angiogenesis, regenerative medicine, and targeted drug delivery. The review takes a critical look at the main advances of PEVs in the treatment of diseases by presenting the latest knowledge from the performed studies, in order to enhance the further translation of the PEVs research into feasible therapeutic applications.
Keywords: Platelets; extracellular vesicles; hemostasis; regenerative medicine; therapy.
Plain language summary
PEVs, derived from platelets, account for the most abundant proportion of all the EVs population found in the plasma. PEVs have drawn much attention due to their significance in intercellular communication and interaction by transporting a variety of molecular cargo. In the review, we summarized the therapeutic potential of PEVs for medical applications, such as cardiovascular diseases, inflammation, regenerative medicine, and targeted drug delivery. Changes in bio-active molecules in PEVs are linked to different agonists and activation methods, and further research on the mechanisms of various PEVs will allow for a new understanding of the development of PEVs as clinical therapeutic products.
Similar articles
-
Platelet-derived extracellular vesicles for drug delivery.Biomater Sci. 2023 Aug 22;11(17):5758-5768. doi: 10.1039/d3bm00893b. Biomater Sci. 2023. PMID: 37489841 Review.
-
Platelets Extracellular Vesicles as Regulators of Cancer Progression-An Updated Perspective.Int J Mol Sci. 2020 Jul 22;21(15):5195. doi: 10.3390/ijms21155195. Int J Mol Sci. 2020. PMID: 32707975 Free PMC article. Review.
-
Platelet-Derived Extracellular Vesicles for Regenerative Medicine.Int J Mol Sci. 2021 Aug 10;22(16):8580. doi: 10.3390/ijms22168580. Int J Mol Sci. 2021. PMID: 34445286 Free PMC article. Review.
-
Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery.J Biomed Sci. 2023 Sep 14;30(1):79. doi: 10.1186/s12929-023-00972-w. J Biomed Sci. 2023. PMID: 37704991 Free PMC article. Review.
-
Platelet-derived- Extracellular Vesicles Promote Hemostasis and Prevent the Development of Hemorrhagic Shock.Sci Rep. 2019 Nov 27;9(1):17676. doi: 10.1038/s41598-019-53724-y. Sci Rep. 2019. PMID: 31776369 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
